{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:56:36Z","timestamp":1790942196108,"version":"4.1.0"},"reference-count":33,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Backgroud\/Objectives: In this exploratory study, we explored the relationship between the timing of recurrence and vaginal cuff length (VCL) in patients with vaginal stump recurrence after hysterectomy. Methods: This is a single-institution study which included 25 consecutive patients who developed postoperative stump recurrence of cervical cancer at Beijing Obstetrics and Gynecology Hospital, Capital Medical University, between January 2013 and December 2024. Patients were divided into early recurrence (\u226424 months) and late recurrence (&gt;24 months) groups according to the postoperative 2-year cutoff point. The relationship between VCL and recurrence time was analyzed with Spearman rank correlation analysis. Receiver operating characteristic (ROC) curve analysis was performed to determine the optimal VCL cutoff value using the Youden index. Kaplan\u2013Meier curves and log-rank tests were used to compare the time to recurrence between groups, stratified by the data-derived VCL cutoff. Results: The median age of the 25 patients was 57 years (range, 36\u201378 years). Squamous cell carcinoma accounted for 68.0% (17\/25) and adenocarcinoma for 24.0% (6\/25). The median VCL was 0.7 cm (range, 0.1\u20132.0 cm), and the median time to recurrence was 22 months (range, 5\u201389 months). Spearman correlation analysis showed a significant positive correlation between VCL and recurrence time (r = 0.804, p &lt; 0.001). ROC curve analysis identified 0.75 cm as the optimal cutoff for predicting early recurrence, with an area under the curve (AUC) of 0.902, a sensitivity of 86.7%, and a specificity of 80.0%. Patients with VCL \u2264 0.75 cm (n = 15) had a median recurrence time of 15 months, compared with 43.5 months in those with VCL &gt; 0.75 cm (n = 10). The proportions of patients remaining free of recurrence at 24 months were 13.3% and 80.0%, respectively (log-rank p &lt; 0.001). Conclusions: In this study, shorter VCL was associated with earlier recurrence, and a data-derived cutoff of 0.75 cm discriminated early (\u226424 months) from late recurrence. Further multicenter studies are needed to validate this finding before changing clinical decisions, given the restricted sample size.<\/jats:p>","DOI":"10.3390\/jcm15197653","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:21:49Z","timestamp":1790940109000},"page":"7653","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vaginal Cuff Length and Time to Postoperative Stump Recurrence After Hysterectomy for Cervical Cancer: An Exploratory Single-Institution Study"],"prefix":"10.3390","volume":"15","author":[{"given":"Yuanjing","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Radiation Therapy Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing 100006, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2666-3891","authenticated-orcid":false,"given":"Siqi","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Radiation Therapy Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing 100006, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4628-8826","authenticated-orcid":false,"given":"Ming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 17 Qihelou St., Dongcheng District, Beijing 100006, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"Yin","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Radiation Therapy Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing 100006, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ijgo.13879","article-title":"Worldwide initiatives to eliminate cervical cancer","volume":"155","author":"Wilailak","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_3","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijgo.13865","article-title":"Cancer of the cervix uteri: 2021 update","volume":"155","author":"Bhatla","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"iv72","DOI":"10.1093\/annonc\/mdx220","article-title":"Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Marth","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.3802\/jgo.2023.34.e42","article-title":"Adjuvant pelvic radiation versus observation in intermediate-risk early-stage cervical cancer patients following primary radical surgery: A propensity score-adjusted analysis","volume":"34","author":"Tuscharoenporn","year":"2023","journal-title":"J. Gynecol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"de Geus, V., Ewing-Graham, P.C., de Koning, W., de Koning, M.N., van den Bosch, T.P., Nigg, A.L., van Eijck, C.H.J., Jozwiak, M., van Beekhuizen, H.J., and Mustafa, D.A. (2022). Identifying Molecular Changes in Early Cervical Cancer Samples of Patients That Developed Metastasis. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.715077"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ygyno.2009.06.001","article-title":"Follow-up for women after treatment for cervical cancer: A systematic review","volume":"114","author":"Elit","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations","volume":"204","author":"Salani","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1634\/theoncologist.2002-0342","article-title":"Guidelines for the treatment of recurrent and metastatic cervical cancer","volume":"7","author":"Friedlander","year":"2002","journal-title":"Oncologist"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMoa1309748","article-title":"Improved survival with bevacizumab in advanced cervical cancer","volume":"370","author":"Tewari","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejso.2011.06.010","article-title":"Vaginal and pelvic recurrence rates based on vaginal cuff length in patients with cervical cancer who underwent radical hysterectomies","volume":"37","author":"Kim","year":"2011","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_14","first-page":"265","article-title":"Five classes of extended hysterectomy for women with cervical cancer","volume":"44","author":"Piver","year":"1974","journal-title":"Obstet. Gynecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(08)70074-3","article-title":"Classification of radical hysterectomy","volume":"9","author":"Querleu","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1245\/s10434-017-6031-z","article-title":"2017 Update on the Querleu-Morrow Classification of Radical Hysterectomy","volume":"24","author":"Querleu","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.2000.6010","article-title":"Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: A prospective randomized study","volume":"80","author":"Landoni","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM199905063401802","article-title":"Vaginal changes and sexuality in women with a history of cervical cancer","volume":"340","author":"Bergmark","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/cncr.11877","article-title":"Early-stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study","volume":"100","author":"Jensen","year":"2004","journal-title":"Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1200\/JCO.2004.00.3996","article-title":"Quality of life and sexual functioning in cervical cancer survivors","volume":"23","author":"Frumovitz","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2005.10.019","article-title":"A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: Follow-up of a gynecologic oncology group study","volume":"65","author":"Rotman","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.6004\/jnccn.2025.0057","article-title":"Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines in Oncology","volume":"23","author":"Campos","year":"2025","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/ijgc-2023-004429","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer\u2014Update 2023","volume":"33","author":"Cibula","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/bjc.2013.716","article-title":"Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: A Korean Gynecologic Oncology Group study","volume":"110","author":"Ryu","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_26","first-page":"1144","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"342","author":"Peters","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.2147\/CMAR.S175726","article-title":"Vaginal cuff length during radical hysterectomy is a prognostic factor for stage IB-IIA cervical cancer: A retrospective study","volume":"10","author":"Zuo","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3857\/roj.2018.00087","article-title":"Adjuvant external beam radiation and brachytherapy for vaginal resection margin positive cervical cancer","volume":"36","author":"Kim","year":"2018","journal-title":"Radiat. Oncol. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bpobgyn.2021.07.005","article-title":"Adjuvant treatment in cervical, vaginal and vulvar cancer","volume":"78","author":"Bhatla","year":"2022","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","article-title":"Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer","volume":"379","author":"Ramirez","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kondo, E., Yoshida, K., Kubo-Kaneda, M., Nii, M., Okamoto, K., Magawa, S., Nimua, R., Okumura, A., Okugawa, T., and Yamawaki, T. (2022). Does Vaginal Cuff Creation and Avoidance of a Uterine Manipulator Improve the Prognosis of Total Laparoscopic Radical Hysterectomy for Early Cervical Cancer? A Retrospective Multicenter Study. Cancers, 14.","DOI":"10.3390\/cancers14184389"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2017.03.022","article-title":"An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations","volume":"146","author":"Salani","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Shan, M., Deng, Y., Zou, W., Fan, S., Li, Y., Liu, X., and Wang, J. (2023). Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: A multicenter retrospective 10-year analysis. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-11406-z"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7653\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:26:21Z","timestamp":1790940381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":33,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["jcm15197653"],"URL":"https:\/\/doi.org\/10.3390\/jcm15197653","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]}}}